Valion Bio (VBIO) Share-based Compensation (2021 - 2026)
Valion Bio (VBIO) posted quarterly Share-based Compensation of -$322000.0 for Q4 2025, down 333.33% quarter-over-quarter from $138000.0 in Q3 2025.
Valion Bio (VBIO) Share-based Compensation (2021 - 2026) Analysis & Trends
Valion Bio's Share-based Compensation history runs 5 years deep, the most recent figure standing at -$322000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation changed N/A year-over-year to -$322000.0; the TTM figure through Dec 2025 stood at -$84000.0 (down 150.6% YoY), while the FY2025 annual figure was $974000.0, up 342.73% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$322000.0, down from $138000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $225000.0 in Q4 2022, with the low at -$322000.0 in Q4 2025.
- The 5-year median for Share-based Compensation is $58000.0 (2023), against an average of $53894.7.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 1306.25% in 2022, then slumped 74.22% in 2023.
- Valion Bio's Share-based Compensation stood at $16000.0 in 2021, then jumped by 1306.25% to $225000.0 in 2022, then plunged by 74.22% to $58000.0 in 2023, then changed by 0.0% to $58000.0 in 2024, then plunged by 655.17% to -$322000.0 in 2025.
- Business Quant data shows VBIO's Share-based Compensation at -$322000.0 in Q4 2025, $138000.0 in Q3 2025, and $104000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | - |
| 10 | Valion Bio | 411,683.63 | -1.79 Mn | -45,000.00 | 133,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133,000.00 |
| Jun 30, 2026 | 133,000.00 |
| Dec 31, 2025 | -322,000.00 |
| Dec 31, 2025 | -322,000.00 |
| Sep 30, 2025 | 138,000.00 |
| Sep 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Sep 30, 2023 | 48,000.00 |